IL158092A0 - Broadspectrum 2- (substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors - Google Patents

Broadspectrum 2- (substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors

Info

Publication number
IL158092A0
IL158092A0 IL15809202A IL15809202A IL158092A0 IL 158092 A0 IL158092 A0 IL 158092A0 IL 15809202 A IL15809202 A IL 15809202A IL 15809202 A IL15809202 A IL 15809202A IL 158092 A0 IL158092 A0 IL 158092A0
Authority
IL
Israel
Prior art keywords
broadspectrum
amino
substituted
protease inhibitors
hiv protease
Prior art date
Application number
IL15809202A
Other languages
English (en)
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of IL158092A0 publication Critical patent/IL158092A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL15809202A 2001-04-09 2002-04-09 Broadspectrum 2- (substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors IL158092A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01201308 2001-04-09
US28770401P 2001-05-02 2001-05-02
PCT/EP2002/004012 WO2002081478A2 (en) 2001-04-09 2002-04-09 Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors

Publications (1)

Publication Number Publication Date
IL158092A0 true IL158092A0 (en) 2004-03-28

Family

ID=26076876

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15809202A IL158092A0 (en) 2001-04-09 2002-04-09 Broadspectrum 2- (substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors

Country Status (25)

Country Link
US (2) US7244752B2 (cs)
EP (1) EP1397367A2 (cs)
JP (1) JP4417010B2 (cs)
KR (1) KR100872029B1 (cs)
CN (1) CN100491360C (cs)
AP (1) AP1544A (cs)
AR (1) AR035819A1 (cs)
AU (1) AU2002257774B2 (cs)
BG (1) BG66371B1 (cs)
BR (1) BR0208796A (cs)
CA (1) CA2442870C (cs)
CZ (1) CZ303139B6 (cs)
EA (1) EA007383B1 (cs)
EE (1) EE05384B1 (cs)
HR (1) HRP20030905B1 (cs)
HU (1) HUP0303744A3 (cs)
IL (1) IL158092A0 (cs)
MX (1) MXPA03009179A (cs)
NO (1) NO328896B1 (cs)
NZ (1) NZ528954A (cs)
OA (1) OA12464A (cs)
PL (1) PL367084A1 (cs)
SK (1) SK288232B6 (cs)
WO (1) WO2002081478A2 (cs)
ZA (1) ZA200307683B (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03009179A (es) * 2001-04-09 2004-11-22 Tibotec Pharm Ltd 2-(amino sustituido)-benzoxazol sunfonamidas, inhibidores de amplio espectro de la vih proteasa.
US7622490B2 (en) * 2001-05-11 2009-11-24 Tibotec Pharmaceuticals, Ltd. Broadspecturm 2-amino-benzoxazole sulfonamide HIV protease inhibitors
WO2003057173A2 (en) * 2002-01-07 2003-07-17 Sequoia Pharmaceuticals Broad spectrum inhibitors
US7285566B2 (en) * 2002-01-07 2007-10-23 Erickson John W Resistance-repellent retroviral protease inhibitors
US7157489B2 (en) 2002-03-12 2007-01-02 The Board Of Trustees Of The University Of Illinois HIV protease inhibitors
IL165043A0 (en) * 2002-05-17 2005-12-18 Tibotec Pharm Ltd broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors
US7807845B2 (en) * 2004-03-11 2010-10-05 Sequoia Pharmaceuticals, Inc. Resistance-repellent retroviral protease inhibitors
WO2005110428A2 (en) * 2004-05-07 2005-11-24 Sequoia Pharmaceuticals, Inc. Resistance-repellent retroviral protease inhibitors
RU2421459C2 (ru) 2005-02-25 2011-06-20 Тиботек Фармасьютикалз Лтд. Синтез предшественника ингибитора протеазы
DE102010044584A1 (de) * 2010-09-07 2012-03-08 Kautex Textron Gmbh & Co. Kg Kraftstoffbehälter aus thermoplastischem Kunststoff
WO2014194519A1 (en) 2013-06-07 2014-12-11 Merck Sharp & Dohme Corp. Imidazole derivatives and methods of use thereof for improving pharmacokinetics of drug

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3021326A1 (de) 1980-06-06 1981-12-17 Drägerwerk AG, 2400 Lübeck Einrichtung zur messung von mindestens zwei pneumatischen lungenparametern und messverfahren hierzu
US4448192A (en) 1982-03-05 1984-05-15 Hewlett Packard Company Medical ventilator device parametrically controlled for patient ventilation
IT1185906B (it) 1985-09-13 1987-11-18 Luciano Gattinoni Sistema ed apparecchio biomedicale per la misurazione con precisione dei valori di variazione di pressione e volume nei polmoni di un paziente
US5136043A (en) 1989-06-17 1992-08-04 Hoechst Aktiengesellschaft Process for the preparation of aromatic sulfonyl chlorides
DE3919840A1 (de) 1989-06-17 1991-01-17 Hoechst Ag Verfahren zur herstellung von aromatischen sulfonsaeurechloriden
EP0445926B1 (en) 1990-03-09 1996-08-21 Milliken Research Corporation Organic materials having sulfonamido linked poly(oxyalkylene) moieties and their preparation
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
PH30929A (en) 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
IS2334B (is) * 1992-09-08 2008-02-15 Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
ATE174587T1 (de) 1993-08-24 1999-01-15 Searle & Co Hydroxyaminosulfonamide verwendbar als inhibitoren retroviraler proteasen
CN1110300C (zh) 1993-10-01 2003-06-04 阿斯特拉公司 工艺技术ⅰ
ES2145252T3 (es) 1993-11-23 2000-07-01 Searle & Co Metodo para elaborar productos intermedios utiles en la sintesis de inhibidores de proteasa retrovirales.
US6143747A (en) * 1995-01-20 2000-11-07 G. D. Searle & Co. Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
US5756533A (en) * 1995-03-10 1998-05-26 G.D. Searle & Co. Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
US6150556A (en) * 1995-03-10 2000-11-21 G. D. Dearle & Co. Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
PL184771B1 (pl) 1995-03-10 2002-12-31 Searle & Co Związek stanowiący hydroksyetyloaminosulfonamid pirolidynokarbonyloaminokwasu, kompozycja zawierająca ten związek, jego zastosowanie do wytwarzania kompozycji do leczenia infekcji retrowirusowej i sposób zapobiegania replikacji retrowirusa in vitro
US5705500A (en) 1995-03-10 1998-01-06 G.D. Searle & Co. Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
US5691372A (en) * 1995-04-19 1997-11-25 Vertex Pharmaceuticals Incorporated Oxygenated-Heterocycle containing sulfonamide inhibitors of aspartyl protease
WO1997018205A1 (en) 1995-11-15 1997-05-22 G.D. Searle & Co. Substituted sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
GB9525994D0 (en) 1995-12-20 1996-02-21 Univ Manitoba Improvements in delivery of assist modes of mechanical ventilation
EP0904060B1 (en) 1996-05-20 2003-12-10 Janssen Pharmaceutica N.V. Antifungal compositions with improved bioavailability
PL190566B1 (pl) 1997-03-26 2005-12-30 Janssen Pharmaceutica Nv Peletka, zawierająca rdzeń pokryty itrakonazolem i polimerem i sposób jej wytwarzania oraz postać dawki farmaceutycznej
SE513969C2 (sv) 1997-05-17 2000-12-04 Draegerwerk Ag Anordning och förfarande för bestämning av respirationssystemetsmekaniska egenskaper
WO1999006254A1 (de) * 1997-07-31 1999-02-11 Continental Teves Ag & Co. Ohg Verfahren und vorrichtung zur aktivierung einer bremsanlage
WO1999033795A1 (en) 1997-12-24 1999-07-08 Vertex Pharmaceuticals Incorporated Prodrugs of aspartyl protease inhibitors
US6436989B1 (en) 1997-12-24 2002-08-20 Vertex Pharmaceuticals, Incorporated Prodrugs of aspartyl protease inhibitors
JP2001527062A (ja) 1997-12-24 2001-12-25 バーテックス ファーマシューティカルズ インコーポレイテッド アスパルチルプロテアーゼインヒビターのプロドラッグ
WO1999033792A2 (en) 1997-12-24 1999-07-08 Vertex Pharmaceuticals Incorporated Prodrugs os aspartyl protease inhibitors
AU4828199A (en) * 1998-06-23 2000-01-10 Board Of Trustees Of The University Of Illinois, The Multi-drug resistant retroviral protease inhibitors and associated methods
AU771780B2 (en) 1998-06-23 2004-04-01 Board Of Trustees Of The University Of Illinois, The Fitness assay and associated methods
HU228938B1 (hu) 1999-10-06 2013-06-28 Us Government Hexahidrofuro[2,3-b]furán-3-il-N-{3-(1,3-benzodioxol-5-il-szulfonil)-(izobutil)-amino-1-benzil-2- -(hidroxi-propil)}-karbamát mint retrovírus proteáz gátló
MXPA03009179A (es) * 2001-04-09 2004-11-22 Tibotec Pharm Ltd 2-(amino sustituido)-benzoxazol sunfonamidas, inhibidores de amplio espectro de la vih proteasa.

Also Published As

Publication number Publication date
US20040132791A1 (en) 2004-07-08
WO2002081478A2 (en) 2002-10-17
ZA200307683B (en) 2005-03-30
CZ303139B6 (cs) 2012-04-25
BR0208796A (pt) 2004-03-09
MXPA03009179A (es) 2004-11-22
EE200300494A (et) 2003-12-15
HUP0303744A2 (hu) 2004-03-01
NO20034505D0 (no) 2003-10-08
AP2003002882A0 (en) 2003-12-31
NO328896B1 (no) 2010-06-07
AU2002257774B2 (en) 2007-08-30
US7244752B2 (en) 2007-07-17
CZ20032936A3 (cs) 2004-05-12
KR100872029B1 (ko) 2008-12-05
CN100491360C (zh) 2009-05-27
CA2442870C (en) 2011-08-02
HRP20030905B1 (en) 2012-03-31
CN1636006A (zh) 2005-07-06
EE05384B1 (et) 2011-02-15
WO2002081478A3 (en) 2003-05-01
AR035819A1 (es) 2004-07-14
NO20034505L (no) 2003-12-08
JP2004529144A (ja) 2004-09-24
HUP0303744A3 (en) 2008-03-28
OA12464A (en) 2006-05-24
CA2442870A1 (en) 2002-10-17
NZ528954A (en) 2005-04-29
AP1544A (en) 2006-01-12
US20070135447A1 (en) 2007-06-14
EP1397367A2 (en) 2004-03-17
EA200301110A1 (ru) 2004-04-29
EA007383B1 (ru) 2006-10-27
HRP20030905A2 (en) 2005-08-31
US7595334B2 (en) 2009-09-29
KR20030090719A (ko) 2003-11-28
BG108218A (bg) 2004-09-30
SK13392003A3 (en) 2004-10-05
PL367084A1 (en) 2005-02-21
SK288232B6 (sk) 2014-11-04
BG66371B1 (bg) 2013-10-31
JP4417010B2 (ja) 2010-02-17

Similar Documents

Publication Publication Date Title
ZA200306086B (en) Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors
NO20042916L (no) HIV integrase inhibitorer
IL158093A0 (en) Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors
HRP20030905A2 (en) Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors
DE50200300D1 (de) Werkzeugmaschine
AP1878A (en) Broadspectrum 2-amino-benzothiazole sulfonamide HIV protease inhibitors.
IL165043A0 (en) broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors
AP2004003083A0 (en) Broadspectrum heterocyclic substituted phenyl containing sulfonamide HIV protease inhibitors
PL375307A1 (en) Broadspectrum substituted oxindole sulfonamide hiv protease inhibitors
HRP20040936A2 (en) Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
TWI340135B (en) Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors
HK1063800A (en) Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors
ATA13902001A (de) Werkzeugmaschine
ZA200500926B (en) Broadspectrum 2-amino-benzothiazole sulfonamide HIV protease inhibitors
AU2002255485A8 (en) Hiv/fiv protease inhibitors
HK1079684A (en) Broadspectrum 2-amino-benzothiazole sulfonamide hiv protease inhibitors
EE00272U1 (et) Sõrmus-hoidja

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees